Instylla Delivery Kit
Device Liquid Embolics for Interventional Radiology
PDI 00812013030000
General payments
$304,025
Research payments
$3,028,613
Through program year 2024, $304,025 in general payments and $3,028,613 in research payments were reported against Instylla Delivery Kit (Liquid Embolics for Interventional Radiology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $139,693 | 118 |
| 2024 | Research | $1,386,642 | 148 |
| 2023 | General | $79,513 | 72 |
| 2023 | Research | $981,923 | 133 |
| 2022 | General | $43,194 | 20 |
| 2022 | Research | $467,576 | 45 |
| 2021 | General | $41,625 | 40 |
| 2021 | Research | $192,473 | 14 |
Breakdown
The top 5 of 44 recipients; each share is of general payments naming this product in 2024.
The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 20 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
250 general · 340 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.